107
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Cell-cycle analysis and micronuclei frequency reveals G0/G1 blockers as weak micronuclei inducers

, , , &
Pages 249-254 | Received 05 May 2012, Accepted 21 Sep 2012, Published online: 05 Nov 2012

References

  • Benameur, L., Orsiere, T., Rose, J., Botta, A. (2011). Detection of environmental clastogens and aneugens in human fibroblasts by cytokinesis-blocked micronucleus assay associated with immunofluorescent staining of CENP-A in micronuclei. Chemosphere 84:676–680.
  • Clare, M. G, Lorenzon, G., Akhurst, L. C., Marzin, D., van Delft, J., Montero, R., et al. (2006). SFTG international collaborative study on in vitro micronucleus test II. Using human lymphocytes. Mutat Res 607:37–60.
  • Cruet-Hennequart, S., Villalan, S., Kaczmarczyk, A., O’Meara, E., Sokol, A. M., Carty, M. P. (2009). Characterization of the effects of cisplatin and carboplatin on cell cycle progression and DNA damage response activation in DNA polymerase eta-deficient human cells. Cell Cycle 8:3039–3050.
  • Fenech, M. (1993). The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutat Res 285:35–44.
  • Ford, J. H., Schultz, C. J., Correll, A. T. (1988). Chromosome elimination in micronuclei: a common cause of hypoploidy. Am J Hum Genet 43:733–740.
  • Heddle, J. A. (1973). A rapid in vitro test for chromosomal damage. Mutat Res 18:187–190.
  • Jeremic, B., Shibamoto, Y., Abe, M. (1996). Assessment of micronucleus induction in murine SCCVII cells treated with various anticancer agents. Chemotherapy 42:266–272.
  • Karl, S., Pritschow, Y., Volcic, M., Hacker, S., Baumann, B., Wiesmuller, L., et al. (2009). Identification of a novel pro-apopotic functions of NF-kappaB in the DNA damage response. J Cell Mol Med 13:4239–4256.
  • Krishnan, A., Hariharan, R., Nair, S. A., Pillai, M. R. (2008). Fluoxetine mediates G0/G1 arrest by inducing functional inhibition of cyclin dependent kinase subunit (CKS) 1. Biochem Pharmacol 75:1924–1934.
  • Leach, N. T., Jackson-Cook, C. (2004). Micronuclei with multiple copies of the X chromosome: do chromosomes replicate in micronuclei? Mutat Res 554:89–94.
  • Maslov, A. Y., Vijg, J. (2009). Genome instability, cancer and aging. Biochim Biophys Acta 1790:963–969.
  • Mateuca, R., Lombaert, N., Aka, P. V., Decordier, I., Kirsch-Volders, M. (2006). Chromosomal changes: induction, detection methods, and applicability in human biomonitoring. Biochimie 88:1515–1531.
  • Matsuzaki, K., Harada, A., Takeiri, A., Tanaka, K., Mishima, M. (2010). Whole cell-ELISA to measure the _H2AX response of six aneugens and eight DNA-damaging chemicals. Mutat Res 700:71–79.
  • Norppa, H., Falck, G. C.-M. (2003). What do human micronuclei contain? Mutagenesis 18:221–233.
  • Singh, N., Nigam, M., Ranjan, V., Sharma, R., Balapure, A. K., Rath, S. K. (2009). Caspase mediated enhanced apoptotic action of cyclophosphamide- and resveratrol-treated MCF-7 cells. J Pharmacol Sci 109:473–485.
  • Suzuki, H., Nakane, S. (1994). Differential induction of chromosomal aberrations by topoisomerase inhibitors in cultured Chinese hamster cells. Biol Pharm Bull 17:222–226.
  • Tedeschi, B., Cicchetti, R., Argentin, G., Caporossi, D., Pittaluga, M., Parisi, P., et al. (2004). Aphidicolin and bleomycin induced chromosome damage as biomarker of mutagen sensitivity: a twin study. Mutat Res 546:55–64.
  • Tripathi, K. D. (1999). Essentials of medical pharmacology. New Delhi, India: Jaypee Brothers Medical Publishers (P) Ltd.
  • Ueno, M., Katayama, K., Yamauchi, H., Nakayama, H., Doi, K. (2006). Cell cycle progression is required for nuclear migration of neural progenitor cells. Brain Res 1088:57–67.
  • Yuan, T. T., Huang, Y., Zhou, C. X., Yu, Y., Wang, L. S., Zhuang, H. Y., et al. (2009). Nuclear translocation of dihydrofolate reductase is not a pre-requisite for DNA damage induced apoptosis. Apoptosis 14:699–710.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.